What amount sold does Capsulomics, Inc. report in Form D filings?

The latest linked filings report $2.4M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Capsulomics, Inc.'s most recent SEC filing?

Capsulomics, Inc.'s most recent Form D filing was on 2025-03-19.

How many investors does Capsulomics, Inc. have?

The most recent Form D filing lists 10 investor(s).

Capsulomics, Inc.

CIK: 0001800623·Biotechnology·HALETHORPE, MD·Corporation

Reported Sold

$2,392,270

Total Filings

Identified Offerings

Last Filed

Mar 19, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Mar 19, 2025Form D/A — Amendment

Reported sold: $2,392,270 · Target: $3,000,000

Rule 506(b)·10 investors

Changed: Reported amount sold, Offering target, Reported investors

Jan 22, 2020Form D — New notice

Reported sold: $50,000 · Target: $50,000

Rule 506(b)·2 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

50%

Latest reported sold across 1 identified offering

$2,392,270

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Daniel Lunz

Related Person

Appears on 2 filings

Stephen Meltzer

Related Person

Appears on 2 filings

John Neiderhuber

Related Person

Appears on 1 filing

William Stevens

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Mar 19, 2025	Amendment	$3,000,000	$2,392,270	10
Jan 22, 2020	New	$50,000	$50,000	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Accufy Diagnostics, Inc.

Biotechnology

Offering target: $2,000,000

Filed Oct 28, 2026